AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-26006851_ITM" title="Facts and information about Press Release: GSK'S Lamictal filed with FDA for first-ever indication in long-term management of depressive episodes in bipolar I disorder.">Press Release: GSK'S Lamictal filed with FDA for first-ever indication in long-term management of depressive episodes in bipolar I disorder.</a>

Close Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.

Frequently asked questions about RSS feeds

Press Release: GSK'S Lamictal filed with FDA for first-ever indication in long-term management of depressive episodes in bipolar I disorder.

Asia Africa Intelligence Wire

| August 29, 2002 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From Chemical Business NewsBase: Press Release)

GlaxoSmithKline (GSK) is seeking the first-ever indication for long-term management of bipolar I disorder to delay the relapse/recurrence of depressive episodes. GSK filed a supplemental New Drug Application to the US Food and Drug Administration (FDA) for Lamictal (lamotrigine). The application for approval of Lamictal as long-term management of adult patients with bipolar I disorder to delay the…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


GSK'S Lamictal Filed With FDA For First-Ever Indication In Long-Term Management...: Press release article from: PR Newswire August 29, 2002 700+ words
...indication for long-term management of bipolar I...recurrence of depressive episodes. GSK filed...Lamictal as long-term management of adult patients...recurrence of depressive episodes is supported...particularly depressive episodes, in patients...requires ...


Lamictal filed with FDA for indication in depressive episodes.: Newspaper article from: Drug Week October 18, 2002 700+ words
...indication for long-term management of bipolar I...recurrence of depressive episodes. GSK filed...Lamictal as long-term management of adult patients...recurrence of depressive episodes is supported...particularly depressive episodes, in patients...requires ...


Discriminating between substance-induced and independent depressive episodes in...: Magazine article from: Journal of Studies on Alcohol Ramsey, Susan E. Kahler, Christopher W. Read, Jennifer P. Stuart, Gregory L. Brown, Richard A. September 1, 2004 700+ words
...commonly made between depressive episodes that are secondary to...remit with abstinence and depressive episodes that are primary and...Schuckit, 1983). Depressive episodes with an onset prior to...


New Study Examines SEROQUEL Treatment for Depressive Episodes Associated With...: News wire article from: AScribe Health News Service May 5, 2004 700+ words
...quetiapine fumarate) as a treatment for depressive episodes that included both patients with...symptoms for those taking SEROQUEL. Depressive episodes are characterized by prolonged periods...examine SEROQUEL as a treatment for depressive episodes that included both patients with...


New Study Examines SEROQUEL Treatment for Depressive Episodes Associated With...: News wire article from: Europe Intelligence Wire May 5, 2004 700+ words
...quetiapine fumarate) as a treatment for depressive episodes that included both patients with...symptoms for those taking SEROQUEL. Depressive episodes are characterized by prolonged periods...examine SEROQUEL as a treatment for depressive episodes that included both patients with...


New Study Examines SEROQUEL Treatment for Depressive Episodes Associated with...: Press release article from: PR Newswire May 5, 2004 700+ words
...quetiapine fumarate) as a treatment for depressive episodes that included both patients with...symptoms for those taking SEROQUEL. Depressive episodes are characterized by prolonged periods...examine SEROQUEL as a treatment for depressive episodes that included both patients with...


FDA Approves Wellbutrin XL(R) (bupropion HCI extended-release tablets) for the...: Press release article from: PR Newswire June 12, 2006 700+ words
...the prevention of seasonal major depressive episodes in patients with a diagnosis of...approved to prevent seasonal major depressive episodes. "Seasonal affective disorder...the prevention of seasonal major depressive episodes in adults diagnosed with SAD is...


Second Investigational Study of SEROQUEL(R) in the Treatment of Depressive...: Press release article from: PR Newswire May 23, 2006 700+ words
...Suicidality Symptoms During Bipolar Depressive Episodes - WILMINGTON, Del., May 23...as a monotherapy treatment for depressive episodes in patients with bipolar I and II...that examined SEROQUEL treatment of depressive episodes in bipolar I and II patients. The...


A group cognitive therapy programme reduced depressive episodes in at risk...: Magazine article from: Evidence-Based Mental Health August 1, 2002 700+ words
...GAF); and risk of incident major depressive episodes. Main results Treatment programme...cumulative risk of incident major depressive episodes at 12 months follow up was lower...symptoms and the cumulative risk of depressive episodes at 12 months follow up. Cognitive...


VALDOXAN GRANTED AUTHORISATION FOR TREATMENT OF DEPRESSIVE EPISODES.: News wire article from: AsiaPulse News February 25, 2009 700+ words
...Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe PARIS, Feb. 25 /PRNewswire-AsiaNet...antidepressant for the treatment of adult patients with major depressive episodes. "There is still great scope for improved therapies...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: